SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 263 filers reported holding SAGE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,072,000 | -60.7% | 62,590 | -49.6% | 0.00% | -66.7% |
Q4 2021 | $5,278,000 | -18.3% | 124,069 | -14.9% | 0.00% | -25.0% |
Q3 2021 | $6,462,000 | -36.5% | 145,826 | -18.6% | 0.00% | -33.3% |
Q2 2021 | $10,176,000 | -29.9% | 179,119 | -7.7% | 0.01% | -25.0% |
Q1 2021 | $14,524,000 | -18.6% | 194,045 | -5.9% | 0.01% | -27.3% |
Q4 2020 | $17,842,000 | +62.6% | 206,243 | +14.9% | 0.01% | +37.5% |
Q3 2020 | $10,974,000 | +90.8% | 179,548 | +29.8% | 0.01% | +100.0% |
Q2 2020 | $5,753,000 | +118.5% | 138,368 | +50.9% | 0.00% | +100.0% |
Q1 2020 | $2,633,000 | -2.2% | 91,692 | +146.0% | 0.00% | 0.0% |
Q4 2019 | $2,691,000 | -60.7% | 37,271 | -23.5% | 0.00% | -66.7% |
Q3 2019 | $6,839,000 | -21.6% | 48,749 | +2.3% | 0.01% | -14.3% |
Q2 2019 | $8,726,000 | +51.0% | 47,662 | +31.2% | 0.01% | +40.0% |
Q1 2019 | $5,780,000 | +160.0% | 36,339 | +56.6% | 0.01% | +150.0% |
Q4 2018 | $2,223,000 | -30.4% | 23,208 | +2.6% | 0.00% | -33.3% |
Q3 2018 | $3,194,000 | -13.7% | 22,610 | -4.4% | 0.00% | -25.0% |
Q2 2018 | $3,702,000 | -2.7% | 23,648 | +0.1% | 0.00% | 0.0% |
Q1 2018 | $3,805,000 | -14.1% | 23,621 | -12.2% | 0.00% | 0.0% |
Q4 2017 | $4,431,000 | +227.7% | 26,901 | +24.0% | 0.00% | +300.0% |
Q3 2017 | $1,352,000 | -24.7% | 21,697 | -3.7% | 0.00% | -50.0% |
Q2 2017 | $1,795,000 | +2.7% | 22,535 | -8.3% | 0.00% | -33.3% |
Q1 2017 | $1,747,000 | +82.5% | 24,576 | +31.2% | 0.00% | +200.0% |
Q4 2016 | $957,000 | -15.2% | 18,734 | -23.6% | 0.00% | -50.0% |
Q3 2016 | $1,129,000 | +111.8% | 24,515 | +38.6% | 0.00% | +100.0% |
Q2 2016 | $533,000 | -22.9% | 17,686 | -17.9% | 0.00% | 0.0% |
Q1 2016 | $691,000 | +53.2% | 21,543 | +178.6% | 0.00% | 0.0% |
Q4 2015 | $451,000 | – | 7,733 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
RA Capital Management | 455,173 | $74,972,000 | 6.27% |
Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |